US Patent Issued to UNISON PHARMACEUTICALS on Sept. 15 for "Pharmaceutical composition comprising combination of sitagliptin and empagliflozin" (Indian Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,188, issued on Sept. 15, was assigned to UNISON PHARMACEUTICALS PVT. LTD. (Ahmedabad, India).

"Pharmaceutical composition comprising combination of sitagliptin and empagliflozin" was invented by Balvir Singh (Ahmedabad, India), Ramesh Shingala (Ahmedabad, India), Milap Patel (Gandhinagar, India) and Ritesh Patel (Ahmedabad, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a stable pharmaceutical composition comprising a fixed dose combination of a therapeutically effective amount of DPP-IV inhibitor and a therapeutically effective amount of SGLT2 inhibitor for reducing blood glucose level in patients with diabet...